OIC Associate Hector Edwards Discusses Medtech Financing Risk and Rewards in the FT’s PWM
A historical cycle of scarcity and survival presents an opportunity for outsized returns in the often misunderstood medical technology investment market.
News & Insights
Oxford Technology & Innovations EIS Fund (OTIF) leads Panda Surgical £1m fundraise.
OTIF is pleased to have led a £1m investment in Panda Surgical, a next-generation neurosurgical robotics company emerging from University College London. This investment underscores our commitment to backing advanced life-science ventures with strong intellectual property and high-impact potential.
OQC Launch First Quantum-AI Data Centre in New York City with Digital Realty Team and NVIDIA
Launch of Quantum-AI Data Centre is a flagship initiative of the UK–US Tech Trade Partnership announced by President Trump and Prime Minister Starmer
Brill Power Acquired by Palmer Energy Technology Ltd (PETL)
The acquisition will see Brill Power technology incorporated into PETL BESS systems immediately to provide world leading BESS solutions.
OTIF participated in a £5m investment supporting the combined venture, alongside FirstGroup plc, Barclays Climate Ventures and Oxford University.
Terumo to Acquire OrganOx in a transaction valued at $1.5 billion USD
We are delighted that OTIF portfolio company OrganOx has accepted an acquisition offer by Terumo Medical Corporation, a leading global medical technology company headquartered in Japan, in a transaction valued at $1.5 billion USD.
This reflects a 12x multiple from the first OTIF investment in 2016.